CONTROVERSIES IN THE TREATMENT OF PLASMA-CELL MYELOMA

被引：26

作者：

BERGSAGEL, DE

机构：

[1] UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA

[2] ONTARIO CANC INST, TORONTO M4X 1K9, ONTARIO, CANADA

来源：

POSTGRADUATE MEDICAL JOURNAL | 1985年 / 61卷 / 712期

关键词：

D O I：

10.1136/pgmj.61.712.109

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：109 / 116

页数：8

共 38 条

[31]

OSGOOD EE, 1960, CANCER CHEMOTH REP, P1

[32] IDENTICAL TWIN MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA [J].

OSSERMAN, EF ;

DIRE, LB ;

DIRE, J ;

SHERMAN, WH ;

HERSMAN, JA ;

STORB, R .

ACTA HAEMATOLOGICA, 1982, 68 (03) :215-223

[33]

PAVLOVSKY S, 1984, J CLIN ONCOLOGY

[34]

RUSSELL RGG, 1975, CLIN ORTHOP RELAT R, V108, P241

[35] ALTERNATING COMBINATION CHEMOTHERAPY AND LEVAMISOLE IMPROVES SURVIVAL IN MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].

SALMON, SE ;

HAUT, A ;

BONNET, JD ;

AMARE, M ;

WEICK, JK ;

DURIE, BGM ;

DIXON, DO .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) :453-461

[36]

SALMON SYDNEY E., 1967, CANCER CHE MOTHER REP, V51, P179

[37]

1968, CANCER CHEMOTHERAPY, V1, P17

[38]

1975, ARCH INTERNAL MED, V135, P147

← 1 2 3 4 →